Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
GenScript logo — Scripting Possibilities - Make People and Nature Healthier t...

GenScript

Scripting Possibilities - Make People and Nature Healthier through Biotechnology

Founded 2002 United States Piscataway, United States 1373 employees IPO Total: $500.00M Biotechnology

General Information

Company Name GenScript
Founded Year 2002
Location United States Piscataway, United States +1
Employees 1373
Industries Biotechnology
Funding Stage IPO
Social

Get notified when GenScript moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

New Partnership Sep 04, 2026

GenScript announced it achieved its fundraising goal for the 10% for Hope campaign in support of the Emily Whitehead Foundation, advancing its mission to support patients and caregivers affected by…

Event Participation Sep 02, 2026

GenScript will be presenting at a webinar on September 23, 2026 to share strategies for accelerating antibody and protein workflows in drug discovery labs.

Growth Metrics Aug 27, 2026

GenScript reports having over 20M+ data points, which fuel its Design-Build-Test-Learn cycle.

Major Customer Win Aug 26, 2026

GenScript celebrates that its GenScript-optimized construct showed strongest performance in a study on codon optimization approaches, leading to a publication in Cell by Dr. Matthew Miller, Dr. Man…

Get alerts when GenScript shows new signals

AI Insight

Bounce Watch AI
1 month ago

GenScript, an established leader in biotechnology, continues to demonstrate strong market validation and strategic expansion, evidenced by a significant $500 million post-IPO equity investment in 2021. Critically, its recently announced technology partnership with Pfizer, integrating GenScript's AmMag™ system into high-throughput antibody workflows, underscores its role as an indispensable enabler for top biopharma companies. This shift highlights GenScript's deep integration into key industry R&D processes and its robust position for sustained growth.

Signal Types
Funding Partnership Product Adoption
Strategic Labels
Strategic Partnerships Technology Validation Growth Capital
Next Move: Expansion
·
Impact: 9/10
·
Ideal For: Growth Equity / Public Market Biotech Investors

About GenScript

GenScript, with its slogan "Scripting Possibilities - Make People and Nature Healthier through Biotechnology," is a prominent player in the biotechnology sector. Originally founded in 2002 in New Jersey, this company is a crucial part of GenScript Biotech Corporation.

The company accelerates biotech and healthcare innovations by offering essential building blocks for developing groundbreaking treatments and products. With a team of approximately 6,165 employees, they support over 200,000 customers, spanning over 100 countries. Among these customers are the world’s top 20 pharma firms, showcasing their extensive reach and influence.

GenScript thrives on collaborations with a diverse network of partners. Its recent $500.00M Post-IPO equity investment on 01 May 2021, led by Hillhouse Capital, underscores investor confidence in their mission to enhance health outcomes through biotechnology.

Taxonomy: Biotech Innovation, Gene Synthesis, Peptide Synthesis, Protein Expression, Antibody Services, Drug Discovery, Industrial Synthetic Biology, Gene Editing, Genome Editing, Gene Therapy, Cell Therapy, Cancer Research, Life Science Solutions, Biotechnology Partnerships, Global Life Science Ecosystem

Services & Products

Gene Services
Protein Services
mRNA Services
CRISPR Services
Peptide Services
Oligo Services

Target Customers

Biopharmaceutical Companies Academic Research Institutions Biotechnology Researchers Pharmaceutical Developers Molecular Biologists

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Post Ipo Equity •••••• 1
Investor
01 May 2021
IPO •••••• - 01 Dec 2015

Latest News

View All
Technical Analysis of Genscript Biotech Corporation (HKEX:1548) — Tradingview.com
Technical Analysis of Genscript Biotech Corporation (HKEX:1548)
Tradingview.com Feb 03, 2018
MilliporeSigma to Collaborate with GenScript to Accelerate Cell and Gene Therapy Industrialization i... — Biospace.com
MilliporeSigma to Collaborate with GenScript to Accelerate Cell and Gene Therapy Industrialization in China
Biospace.com Mar 19, 2019
Chinese CDMO GenScript takes steps to be player in China's gene and cell therapy market — Fiercepharma.com
Chinese CDMO GenScript takes steps to be player in China's gene and cell therapy market
Fiercepharma.com Jul 23, 2019
Genscript seeks EUA for test that indicates immunity to COVID-19 — Bioworld.com
Genscript seeks EUA for test that indicates immunity to COVID-19
Bioworld.com Jun 03, 2020
A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike p... — Nature.com
A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction
Nature.com Jul 23, 2020
Genscript snags FDA nod for first test to detect neutralizing antibodies to COVID-19 — Bioworld.com
Genscript snags FDA nod for first test to detect neutralizing antibodies to COVID-19
Bioworld.com Nov 09, 2020

GenScript Alternatives & Competitors

View All Alternatives
GenScript vs
Tsingke Biotech
Tsingke Biotech China

Leading DNA/RNA synthesis innovator, delivering advanced synthetic genomics products for groundbreak...

Series B
13 employees
Biotechnology, Health Care
Compare GenScript vs Tsingke Biotech
GenScript vs
Alta Biotech, LLC.
Alta Biotech, LLC. United States

Specializing in plasmid DNA production and services for life science research

6 employees
Biotechnology, Life Sciences
Compare GenScript vs Alta Biotech, LLC.
GenScript vs
Bio Basic Inc.
Bio Basic Inc. Canada

Quality-Affordable Research

55 employees
Biotechnology, Life Sciences
Compare GenScript vs Bio Basic Inc.
View all alternatives

FAQ About GenScript

Scripting Possibilities - Make People and Nature Healthier through Biotechnology
GenScript was founded in 2002.
GenScript is headquartered in Piscataway, United States.
GenScript operates in the following industries: Biotechnology.
GenScript has approximately 1373 employees.
GenScript has completed 2 funding rounds, raising a total of $500.00M. The latest funding stage is IPO.
GenScript offers: Gene Services, Protein Services, mRNA Services, CRISPR Services, Peptide Services, Oligo Services.
Top alternatives and competitors to GenScript include Tsingke Biotech, Alta Biotech, LLC., Bio Basic Inc., Cytiva, Beijing SBS Genetech Co., Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
GenScript and Tsingke Biotech are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors GenScript and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy